Science Abstracts
Developing clinical role of a CCR5 co-receptor antagonist in HIV-1 infection
May 2012
May 2012
Authors : David J Caldwell1 , Jeffery D Evans2
Affliation :
1Assistant Professor of Clinical and Administrative Sciences ULM College of Pharmacy, 1800 Bienville Drive, Monroe, LA 71201, USA ; ; dcaldwell@ulm.edu
2Assistant Professor of Clinical and Administrative Sciences ULM College of Pharmacy, 1725 Claiborne Ave., Shreveport, LA 71103, USA
DOI : 10.1517/14656560802576324
Published in : Expert Opin. Pharmacother.
Subject: Drug Evaluation
Keywords: CCR5 , chemokine coreceptor antagonist , HIV-1 infection , maraviroc , UK-427857
Abstract
Please Login to read the full article.
RELATED CONTENT
NEWS
- UK govt offers "step change" in support for regenerative medicine
- InSite to raise $22M to advance PhIII pipeline including combo product for lid margin disease
- ASEAN issues call for dengue action as cases rise
- Big pharma abandoning HIV discounts in middle-income countries, MSF claims
